Literature DB >> 26966933

Hormones and endometrial carcinogenesis.

Areege Kamal, Nicola Tempest, Christina Parkes, Rafah Alnafakh, Sofia Makrydima, Meera Adishesh, Dharani K Hapangama.   

Abstract

Endometrial cancer (EC) is the commonest gynaecological cancer in the Western World with an alarmingly increasing incidence related to longevity and obesity. Ovarian hormones regulate normal human endometrial cell proliferation, regeneration and function therefore are implicated in endometrial carcinogenesis directly or via influencing other hormones and metabolic pathways. Although the role of unopposed oestrogen in the pathogenesis of EC has received considerable attention, the emerging role of other hormones in this process, such as androgens and gonadotropin-releasing hormones (GnRH) is less well recognised. This review aims to consolidate the current knowledge of the involvement of the three main endogenous ovarian hormones (oestrogens, progesterone and androgens) as well as the other hormones in endometrial carcinogenesis, to identify important avenues for future research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26966933     DOI: 10.1515/hmbci-2016-0005

Source DB:  PubMed          Journal:  Horm Mol Biol Clin Investig        ISSN: 1868-1883


  11 in total

1.  Estrogen and insulin synergistically promote type 1 endometrial cancer progression.

Authors:  Wenyan Tian; Fei Teng; Jing Zhao; Jinping Gao; Chao Gao; Dandan Sun; Guoyan Liu; Yanfang Zhang; Shizhu Yu; Wei Zhang; Yingmei Wang; Fengxia Xue
Journal:  Cancer Biol Ther       Date:  2017-11-27       Impact factor: 4.742

Review 2.  Immunotherapy in endometrial cancer: rationale, practice and perspectives.

Authors:  Wenyu Cao; Xinyue Ma; Jean Victoria Fischer; Chenggong Sun; Beihua Kong; Qing Zhang
Journal:  Biomark Res       Date:  2021-06-16

Review 3.  Cigarette Smoking and Estrogen-Related Cancer.

Authors:  John A Baron; Hazel B Nichols; Chelsea Anderson; Stephen Safe
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-05-14       Impact factor: 4.254

Review 4.  Artificial intelligence: A rapid case for advancement in the personalization of Gynaecology/Obstetric and Mental Health care.

Authors:  Gayathri Delanerolle; Xuzhi Yang; Suchith Shetty; Vanessa Raymont; Ashish Shetty; Peter Phiri; Dharani K Hapangama; Nicola Tempest; Kingshuk Majumder; Jian Qing Shi
Journal:  Womens Health (Lond)       Date:  2021 Jan-Dec

5.  Harmonisation of biobanking standards in endometrial cancer research.

Authors:  M Adishesh; A Fyson; S B DeCruze; J Kirwan; H M J Werner; D K Hapangama
Journal:  Br J Cancer       Date:  2017-06-29       Impact factor: 7.640

Review 6.  Implications of telomeres and telomerase in endometrial pathology.

Authors:  D K Hapangama; A Kamal; G Saretzki
Journal:  Hum Reprod Update       Date:  2017-03-01       Impact factor: 15.610

Review 7.  Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: A NCI clinical trials planning meeting report.

Authors:  Stephanie Lheureux; Carolyn McCourt; B J Rimel; Linda Duska; Gini Fleming; Helen Mackay; David Mutch; Sarah M Temkin; Jean Lynn; Elise C Kohn
Journal:  Gynecol Oncol       Date:  2018-02-22       Impact factor: 5.304

Review 8.  Human Uterine Biopsy: Research Value and Common Pitfalls.

Authors:  Alison Maclean; Areege Kamal; Meera Adishesh; Rafah Alnafakh; Nicola Tempest; Dharani K Hapangama
Journal:  Int J Reprod Med       Date:  2020-04-28

9.  High AGR2 protein is a feature of low grade endometrial cancer cells.

Authors:  Areege Kamal; Anthony Valentijn; Roger Barraclough; Philip Rudland; Nihad Rahmatalla; Pierre Martin-Hirsch; Helen Stringfellow; Shandya B Decruze; Dharani K Hapangama
Journal:  Oncotarget       Date:  2018-07-31

10.  Telomere and Telomerase-Associated Proteins in Endometrial Carcinogenesis and Cancer-Associated Survival.

Authors:  Lucy Button; Bryony Rogers; Emily Thomas; Alice Bradfield; Rafah Alnafakh; Josephine Drury; Dharani K Hapangama
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.